Updated: January 17, 2026
Alternatives to Plavix (Clopidogrel) If You Can't Fill Your Prescription
Author
Peter Daggett

Overview
Can't fill your clopidogrel prescription? Learn about the antiplatelet alternatives your doctor may consider — including ticagrelor, prasugrel, and aspirin.
Is Plavix in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Plavix near you.
Important warning: Never stop clopidogrel or switch antiplatelet medications on your own. These medications prevent life-threatening blood clots — particularly if you have a coronary stent or have recently had a heart attack or stroke. Any change must be made under your doctor's supervision. This article is intended to help you have an informed conversation with your healthcare provider.
There are situations where a clopidogrel alternative may be needed: your pharmacy is temporarily out of stock, you have discovered you are a CYP2C19 poor metabolizer, you are experiencing a drug interaction (such as with omeprazole), or the cost has become a barrier. In those cases, your doctor has several evidence-based options to consider.
Why Clopidogrel Doesn't Work the Same for Everyone
Clopidogrel is a prodrug — it has no antiplatelet activity on its own. Your liver must convert it into an active metabolite using an enzyme called CYP2C19. Roughly 2-14% of people (and up to 50% or more in some East Asian populations) carry genetic variants that impair this enzyme, reducing or eliminating clopidogrel's effectiveness. This is why the FDA added a boxed warning in 2010, and why providers increasingly order CYP2C19 genetic tests before or after starting clopidogrel.
If you are a poor metabolizer, clopidogrel may feel like it is working but may not be adequately preventing clots. In that case, your doctor is likely to switch you to one of the alternatives below.
Check live stock now.
Alternative 1: Ticagrelor (Brilinta)
Ticagrelor is the most commonly recommended alternative to clopidogrel for acute coronary syndrome. It is a P2Y12 inhibitor like clopidogrel, but it works differently — it is not a prodrug, so it does not depend on CYP2C19 metabolism. This means it works consistently regardless of your genetic makeup.
Advantages over clopidogrel:
- Faster onset of action and more potent platelet inhibition
- Reversible binding — easier to stop before surgery
- Not affected by omeprazole or PPI interactions
- Shown to reduce cardiovascular death vs. clopidogrel in the PLATO trial
Disadvantages:
- Must be taken twice daily (clopidogrel is once daily)
- Can cause shortness of breath (dyspnea) in some patients
- Higher bleeding risk than clopidogrel
- Costs more — generic ticagrelor is approximately $30-$80/month vs. $4-$10/month for clopidogrel
Alternative 2: Prasugrel (Effient)
Prasugrel is a third-generation thienopyridine P2Y12 inhibitor — the same drug class as clopidogrel, but more potent. Like clopidogrel, it is a prodrug, but its activation pathway is less dependent on CYP2C19, making it more reliable in poor metabolizers.
Advantages over clopidogrel:
- Once-daily dosing (same as clopidogrel)
- Faster and more consistent platelet inhibition
- Reduced stent thrombosis risk vs. clopidogrel in the TRITON-TIMI 38 trial
Disadvantages and important restrictions:
- Contraindicated in patients with a history of stroke or TIA
- Higher risk of major bleeding than clopidogrel
- Not recommended for patients 75 years or older, or those weighing less than 60 kg, unless the benefit clearly outweighs the risk
Alternative 3: Aspirin/Dipyridamole (Aggrenox)
Aspirin/dipyridamole (brand name Aggrenox) is a combination antiplatelet tablet used primarily for secondary stroke prevention — not for coronary artery disease or stent protection. If you are on clopidogrel specifically for stroke prevention, your neurologist may consider Aggrenox as an alternative. It works by inhibiting platelet function through a different mechanism than P2Y12 inhibitors.
Alternative 4: Aspirin Alone
For patients on long-term clopidogrel for secondary prevention of heart attack or stroke (not for a recent stent), aspirin alone at 81-100 mg/day is sometimes used when clopidogrel cannot be tolerated or obtained. However, aspirin is significantly less potent as a standalone antiplatelet agent. This should only be considered as a temporary bridge under strict physician guidance.
Which Alternative Is Right for You?
Your doctor will consider several factors when choosing an alternative:
- Your CYP2C19 genotype (if tested)
- Whether you have had a stroke or TIA (rules out prasugrel)
- Your bleeding risk (older patients or those on anticoagulants may do better on clopidogrel's lower bleeding risk profile)
- The reason you are on an antiplatelet (post-stent, post-MI, stroke prevention, or PAD)
- Cost and insurance coverage
Before switching medications, make sure you've truly exhausted your options for finding clopidogrel. medfinder can call pharmacies near you to check stock, often finding it faster than you could on your own. Generic clopidogrel at $4/month is hard to beat on cost, and most patients continue on it long-term without issue.
Also read: Plavix Side Effects: What to Expect and When to Call Your Doctor for a full breakdown of when switching might be warranted due to side effects.
Frequently Asked Questions
For most patients with acute coronary syndrome, ticagrelor (Brilinta) is the most commonly recommended alternative. It doesn't depend on CYP2C19 metabolism and provides faster, more potent platelet inhibition. Prasugrel (Effient) is another option, though it carries more bleeding risk and is contraindicated in patients with stroke history.
No. You should never switch antiplatelet medications without your doctor's guidance. Changing the timing, dose, or agent can leave you temporarily unprotected from blood clots. Your cardiologist or prescriber should coordinate any switch, including proper dosing and timing.
In clinical trials (particularly the PLATO trial), ticagrelor reduced cardiovascular death and major adverse events compared to clopidogrel in ACS patients. However, it also carries a higher bleeding risk and must be taken twice daily. Whether it is better for you depends on your individual clinical situation.
Generally no — aspirin alone is not a sufficient replacement for clopidogrel in the months immediately following a coronary stent. Stopping antiplatelet therapy prematurely after stent placement dramatically increases your risk of stent thrombosis, which can be fatal. Never stop clopidogrel after a stent without explicit guidance from your interventional cardiologist.
Yes. Prasugrel's activation is less dependent on CYP2C19 than clopidogrel, making it a more reliable option for patients identified as CYP2C19 poor metabolizers. However, prasugrel is contraindicated in patients with a history of stroke or TIA, so not all poor metabolizers are candidates.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Plavix also looked for:
More about Plavix
37,770 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





